Cytovale

Cytovale company information, Employees & Contact Information

Explore related pages

Related company profiles:

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale

Company Details

Employees
125
Founded
-
Address
2 Tower Pl,
Phone
562-881-6919
Email
in****@****ale.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
medical device.
HQ
South San Francisco, California
Looking for a particular Cytovale employee's phone or email?

Cytovale Questions

News

Accelerated Demand for Cytovale's FDA-Cleared Sepsis Detection Solution, IntelliSep®, to Drive Growth in 2025 - PR Newswire

Accelerated Demand for Cytovale's FDA-Cleared Sepsis Detection Solution, IntelliSep®, to Drive Growth in 2025 PR Newswire

ICU-Level Care Not Definitive Indicator for Sepsis, New Study Shows - PR Newswire

ICU-Level Care Not Definitive Indicator for Sepsis, New Study Shows PR Newswire

Cytovale Names Rhonda Collins Chief Nursing Officer - PR Newswire

Cytovale Names Rhonda Collins Chief Nursing Officer PR Newswire

Cellular host response sepsis test for risk stratification of patients in the emergency department: A pooled analysis - Wiley Online Library

Cellular host response sepsis test for risk stratification of patients in the emergency department: A pooled analysis Wiley Online Library

Cytovale gains momentum with $100M for its sepsis screening test - Fierce Biotech

Cytovale gains momentum with $100M for its sepsis screening test Fierce Biotech

Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments - Business Wire

Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments Business Wire

Cytovale’s sepsis diagnostic test demonstrates 97.5% NPV in latest study - Clinical Trials Arena

Cytovale’s sepsis diagnostic test demonstrates 97.5% NPV in latest study Clinical Trials Arena

Why Hospital EDs Are Adopting Cytovale’s Sepsis Test - MedCity News

Why Hospital EDs Are Adopting Cytovale’s Sepsis Test MedCity News

Cytovale: Best in Business 2024 - Modern Healthcare News

Cytovale: Best in Business 2024 Modern Healthcare News

Cytovale Secures $100M to Expand Commercialization of FDA-Cleared Sepsis Test - HIT Consultant

Cytovale Secures $100M to Expand Commercialization of FDA-Cleared Sepsis Test HIT Consultant

Machine learning medical diagnostics company Cytovale scores $84M - Mobi Health News

Machine learning medical diagnostics company Cytovale scores $84M Mobi Health News

Cytovale raises $84M Series C for sepsis diagnostic - MassDevice

Cytovale raises $84M Series C for sepsis diagnostic MassDevice

Cytovale Names Dave Vort Chief Commercial Officer - PR Newswire

Cytovale Names Dave Vort Chief Commercial Officer PR Newswire

Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools - Business Wire

Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools Business Wire

Cytovale collects $84M to roll out its rapid ER sepsis diagnostic test - Fierce Biotech

Cytovale collects $84M to roll out its rapid ER sepsis diagnostic test Fierce Biotech

Cytovale Recognized as One of Modern Healthcare's 2024 Best in Business - PR Newswire

Cytovale Recognized as One of Modern Healthcare's 2024 Best in Business PR Newswire

Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution - PR Newswire

Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution PR Newswire

Cytovale Secures $84 Million Series C to Advance Commercialization of Transformative Sepsis Diagnostic Tool - PR Newswire

Cytovale Secures $84 Million Series C to Advance Commercialization of Transformative Sepsis Diagnostic Tool PR Newswire

Christopher Slachta Joins Cytovale as Chief Operating Officer - PR Newswire

Christopher Slachta Joins Cytovale as Chief Operating Officer PR Newswire

Cytovale's FDA-Cleared Sepsis Diagnostic Triages First 5,000 Patients, Paves Way to New Hospital Protocols for Sepsis Management - PR Newswire

Cytovale's FDA-Cleared Sepsis Diagnostic Triages First 5,000 Patients, Paves Way to New Hospital Protocols for Sepsis Management PR Newswire

Cytovale™ IntelliSep™ Test Demonstrates Potential to Rapidly Risk-Stratify Suspected COVID-19 Patients in New Study - Business Wire

Cytovale™ IntelliSep™ Test Demonstrates Potential to Rapidly Risk-Stratify Suspected COVID-19 Patients in New Study Business Wire

FDA clears new sepsis diagnostic from Cytovale - MassDevice

FDA clears new sepsis diagnostic from Cytovale MassDevice

Cytovale Raises $15M in Funding - FinSMEs

Cytovale Raises $15M in Funding FinSMEs

Top Cytovale Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant